1.Conclusion Oral administration of alloantigen can down-regulate the immune response to histocompatibility antigens, prolong the survival times of heart allografts.
结论:口服抗原可以引起受者对异基因抗原的特异性免疫反应降低,使受者的心脏移植存活期延长。
2.Conclusion Oral administration of alloantigen can down-regulate the immune response to histocompatibility antigens, prolong the survival times of heart allografts.
结论:口服抗原可以引起受者对异基因抗原的特异性免疫反应降低,使受者的心脏移植存活期延长。